University of Florida
Gainesville, Florida, 32611, United States
Location status: Recruiting
Location contact
Julia Choi
CONTACT
NCT Number: NCT06911229
Locomotor adaptation will be studied using an established split-belt treadmill paradigm, consisting of baseline (1:1 speed ratio), split-belt adaptation (2:1) and post-adaptation (1:1) walking. Split-belt walking will be performed under DBS ON and DBS OFF conditions, while off-medication.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Gainesville, Florida, 32611, United States
Location status: Recruiting
Julia Choi
CONTACT
We will test the hypotheses that DBS can facilitate split-belt walking adaptation with DBS ON compared with DBS OFF.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will receive DBS in the clinically-optimized setting.
Time frame: 1 hour
The rate of adaptation in step length asymmetry is estimated by fitting an exponential decay function to step length asymmetry over the first 100 strides in adaptation.
Time frame: 1 hour
The magnitude of adaptation in step length asymmetry is calculated as the mean difference in step length asymmetry between early and late adaptation.
Time frame: 1 hour
The after-effect in step length asymmetry is calculated as the mean difference in step length asymmetry between baseline and early post-adaptation.
Contact information is provided by the study sponsor or research team.
University of Florida
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07786116
Alzheimer Dementia, Alzheimer Dementia (AD)
Cambridge, CB2, United Kingdom
View Trial DetailsNCT06994728
Basal Ganglia Diseases, Brain Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT04664634
Basal Ganglia Diseases, Brain Diseases
Evanston, Illinois, United States
View Trial DetailsNCT07674264
Basal Ganglia Diseases, Brain Diseases
Gainesville, Florida, United States
View Trial Details